SCHEMBL15899150

SCHEMBL15899150

CC1(C)OCC(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)(Cn2cc(CO)nc2[N+](=O)[O-])CO1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SMYD2 Q9NRG4 3/20 0.34
▸ ABL1 P00519 1/20 0.32
▸ LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15899159 0.88 SMYD2 (0.34) SMYD2ABL1LMNA
SCHEMBL15899177 0.87 SMYD2 (0.32) SMYD2ABL1
SCHEMBL15899130 0.87 SMYD2 (0.33) SMYD2
SCHEMBL15899202 0.86 SMYD2 (0.33) SMYD2
SCHEMBL15899125 0.83 CYP3A4 (0.37) SMYD2ABL1LMNA
SCHEMBL14822359 0.81 — —
SCHEMBL15899359 0.77 CA12 (0.36) SMYD2ABL1
SCHEMBL21694640 0.76 SMYD2 (0.39) SMYD2
SCHEMBL15899147 0.75 — —
SCHEMBL15899276 0.74 SMYD2 (0.36) SMYD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2759538-B1 RADIOACTIVE FLUORINE LABELED COMPOUND NIHON MEDIPHYSICS CO LTD (JP) 2016-03-23 — — EP disclosed
US-9107964-B2 Radioactive fluorine-labeled compound NIHON MEDI-PHYSICS CO., LTD. (JP) 2015-08-18 — — US disclosed
US-20140364620-A1 RADIOACTIVE FLUORINE-LABELED COMPOUND NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2014-12-11 — — US disclosed
EP-2759538-A1 RADIOACTIVE FLUORINE LABELED COMPOUND Nihon Medi-Physics Co., Ltd. (JP) 2014-07-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140364620-A1 RADIOACTIVE FLUORINE-LABELED COMPOUND AFF1, PRMT1, DOT1L SMYD2 319/4885ABL1 217/4885LMNA 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback